1. Home
  2. TEVA vs NWSA Comparison

TEVA vs NWSA Comparison

Compare TEVA & NWSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • NWSA
  • Stock Information
  • Founded
  • TEVA 1901
  • NWSA 2012
  • Country
  • TEVA Israel
  • NWSA United States
  • Employees
  • TEVA N/A
  • NWSA N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • NWSA Newspapers/Magazines
  • Sector
  • TEVA Health Care
  • NWSA Consumer Discretionary
  • Exchange
  • TEVA Nasdaq
  • NWSA Nasdaq
  • Market Cap
  • TEVA 19.2B
  • NWSA 16.1B
  • IPO Year
  • TEVA N/A
  • NWSA N/A
  • Fundamental
  • Price
  • TEVA $17.12
  • NWSA $29.49
  • Analyst Decision
  • TEVA Strong Buy
  • NWSA Strong Buy
  • Analyst Count
  • TEVA 8
  • NWSA 5
  • Target Price
  • TEVA $19.63
  • NWSA $36.25
  • AVG Volume (30 Days)
  • TEVA 7.8M
  • NWSA 3.1M
  • Earning Date
  • TEVA 11-06-2024
  • NWSA 11-07-2024
  • Dividend Yield
  • TEVA N/A
  • NWSA 0.68%
  • EPS Growth
  • TEVA N/A
  • NWSA 158.28
  • EPS
  • TEVA N/A
  • NWSA 0.62
  • Revenue
  • TEVA $16,772,000,000.00
  • NWSA $10,163,000,000.00
  • Revenue This Year
  • TEVA $4.70
  • NWSA $5.43
  • Revenue Next Year
  • TEVA $4.47
  • NWSA $3.55
  • P/E Ratio
  • TEVA N/A
  • NWSA $47.57
  • Revenue Growth
  • TEVA 9.81
  • NWSA 2.66
  • 52 Week Low
  • TEVA $9.35
  • NWSA $21.52
  • 52 Week High
  • TEVA $19.31
  • NWSA $30.04
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 44.64
  • NWSA 68.60
  • Support Level
  • TEVA $16.15
  • NWSA $28.72
  • Resistance Level
  • TEVA $17.17
  • NWSA $29.35
  • Average True Range (ATR)
  • TEVA 0.49
  • NWSA 0.65
  • MACD
  • TEVA -0.04
  • NWSA 0.03
  • Stochastic Oscillator
  • TEVA 30.54
  • NWSA 79.85

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About NWSA News Corporation

News Corporation is a diversified media conglomerate with significant presence in the us, the UK, and Australia. Key mastheads include The Wall Street Journal, Barron's, New York Post, The Times, The Sun, The Australian, Herald Sun, and The Daily Telegraph. The company also has a strong presence in the Australian subscription video market through 65%-owned Foxtel, and streaming platforms such as sport-focused Kayo and entertainment-focused Binge. Its 61%-owned REA Group is the dominant property listings business in Australia. In addition, it owns Harper Collins, one of the biggest book publishers in the world, and has a sizable us digital property advertising business, Move.

Share on Social Networks: